We had some great input from one of our mentors, Kevin D'Antonio - Director Strategy & Innovation at EY
"Great job team. Just thoughts : what is the incentive for people to give / to receive the treatments ? Why not getting an innovative business model where people(human) can donate or receive benefits from their plasma etc. (Maybe border line but...)"
And in response: There are ethical concerns with that - normally people who donate get a fee (that is built into the business model for our costs). And the fees can be a lot more - there is a trial in the UK on actually giving people a less-virulent strain of the virus in a safe environment to study them… and they got $4,500 for the 3 months trial
When we get to scale, it is better to have donations for the healthcare workers… but in addition we realized we need greater scale for the future, hence using cows
A human donor gives 200-250ml (and those antibodies will help 1 person for 2 months). A cow slaughtered (after a couple of months - one option) would be 12-15 liters of blood - so 40-50X more (otherwise we keep the cows alive and take about 5 liters per 4 months)
It is nice to think about being more innovative in the pricing - but it is a highly regulated market place!
Log in or sign up for Devpost to join the conversation.